Despite health concerns, the increasing popularity of OTC drugs has led to pharma majors seizing the chance to diversify ...

Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharma introduces generic Xalatan ophthalmic solution, 0.005% in US: Our Bureau, Mumbai Friday, February 14, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Gle ...

Glenmark Pharmaceuticals Inc ... and oncology therapeutic areas across its branded, generic, and OTC segments. The company ranks among the top 100 biopharmaceutical companies by pharmaceutical ...

Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial: Our Bureau, Mumbai Thursday, February 27, 2025, 12:30 Hrs [IST] Glenmark Pharmaceutic ...

(BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments ... different types of products and services to ...

As part of the agreement inked in September 2023, Glenmark in-licensed the product from Cosmo Pharmaceuticals for distribution in Europe and South Africa. "Our partnership with Cosmo Pharmaceuticals ...

today announced that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi® in the United Kingdom. Winlevi® is a topical treatment ...

Glenmark said in a stock exchange filing that the newly launched product is bioequivalent and therapeutically equivalent to ...